somatostatin antagonists (Novartis)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namesomatostatin antagonists (Novartis)
Drug Alias NameNVP-ACQ090SRA-880CH-275NVP-SRA880
ClassificationSmall molecules
Mechanisms of ActionSomatostatin receptor 3 antagonistsSomatostatin receptor 1 antagonistsGrowth hormone release stimulants
TargetsSomatostatin receptor 3Somatostatin receptor 1
Therapy Area/IndicationsAnxiety DisordersMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsAnxiety DisordersMental Disorders

Other Information

ATC CodeN/A
Related LinksN/A